Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lithium Americas Corp (LAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lithium Americas Corp — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $85.02 (market cap $48.56B), while Lithium Americas Corp trades at $2.35 (market cap $850.38M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 57.1× Lithium Americas Corp's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Lithium Americas Corp nearer its low. Which is the better fit depends on your goals.
| EW | LAC | |
|---|---|---|
Market Cap | $48.56B | $850.38M |
Volume | 6,520,488 | 8,804,637 |
Sector | Health | Basic Materials |
52-Week High | $95.18 | $10.05 |
52-Week Low | $72.65 | $2.36 |
Enterprise Value | $45.01B | $1.19B |
Typical Hold Time | — | 27 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lithium Americas (LAC) trades at $2.34, down 2.9% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company shows negative profitability metrics with ROE at -9.56% and ROA at -3.99%, though it has beaten earnings expectations in recent quarters. Cash flow remains supported by financing activities as the company invests heavily in Thacker Pass development. Analyst consensus is mixed with 7 buy ratings and 8 hold ratings, with a $4.00 price target representing 71% upside potential.
LAC presents a high-risk, high-reward opportunity as it transitions from development to execution phase. The primary catalyst is successful construction and operation of Thacker Pass, but investors face significant execution risk, negative cash flow from operations, and lithium price volatility. The stock trades at a discount to book value (P/B 0.6), offering potential upside if operational milestones are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →
